- 2024.3.13
- News Release Prof. Yohei Yamauchi of ETH Zurich and TAGCyx Announces a Research Collaboration for the discovery of a novel Xenoligo® aptamer in the field of infectious diseases field.
- 2024.3.11
- News Release Shinji Oki, PhD, at National Center of Neurology and Psychiatry and TAGCyx Announces a research collaboration for the treatment for systemic lupus erythematosus using a novel nucleic acid aptamer.
- 2024.2.29
- Patents, Articles & Conferences We will be presenting Xenoligo® Technology at Aptamers 2024 (March 18th – 19th at Oxford）
- 2024.1.31
- News Release SBI Pharmaceuticals and TAGCyx ANNOUNCES A MILESTONE ACHIEVEMENT OF THE RESEARCH AND DEVELOPMENT COLLABORATION OF INNOVATIVE CANCER THERAPY
- 2024.1.4
- News Release TAGCyx and Toray Launch Joint Research Initiative to Combat Preeclampsia during Pregnancy as Part of Efforts to Stem Japan’s Declining Birthrate
- 2023.12.12
- News Release TAGCyx has executed a joint research and development agreement with Teika Pharmaceutical
- 2023.11.15
- Patents, Articles & Conferences We are pleased to announce that the result of our research on a novel anti IFN-γDNA aptamer treatment for Hunner-type interstitial cystitis with Dr. Yoshiyuki Akiyama, University of Tokyo Hospital and Dr. Yi Luo, University of Iowa, have been accepted and published online in iScience.
- 2023.10.31
- Patents, Articles & Conferences Announcement of presentation at the 43rd Annual Scientific Meeting of the Japanese Society of Ocular Pharmacology (November 11 – 12, 2023)
- 2023.10.3
- Information Science Impact magazine published an article about the treatment for Hunner-type interstitial cystitis using TAGCyx’s aptamer, TAGX-0003.
- 2023.9.15
- Patents, Articles & Conferences Announcement of presentation at the 44th Annual Meeting of the Japanese Society for Apheresis (October 20 – 22, 2023)
- 2023.9.13
- Event We will have a booth V-36 at Japan Healthcare Venture Summit 2023 on Oct 11st-13rd
- 2023.5.29
- Information Announcing the renovating of TAGCyx website